Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015633
Filing Date
2021-11-12
Accepted
2021-11-12 07:05:43
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akus-20210930x10q.htm   iXBRL 10-Q 2115151
2 EX-31.1 akus-20210930xex31d1.htm EX-31.1 15414
3 EX-31.2 akus-20210930xex31d2.htm EX-31.2 15407
4 EX-32.1 akus-20210930xex32d1.htm EX-32.1 13858
  Complete submission text file 0001558370-21-015633.txt   7189001

Data Files

Seq Description Document Type Size
5 EX-101.SCH akus-20210930.xsd EX-101.SCH 37625
6 EX-101.CAL akus-20210930_cal.xml EX-101.CAL 49968
7 EX-101.DEF akus-20210930_def.xml EX-101.DEF 142901
8 EX-101.LAB akus-20210930_lab.xml EX-101.LAB 391357
9 EX-101.PRE akus-20210930_pre.xml EX-101.PRE 296896
10 EXTRACTED XBRL INSTANCE DOCUMENT akus-20210930x10q_htm.xml XML 1238989
Mailing Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210
Business Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210 857-245-5715
Akouos, Inc. (Filer) CIK: 0001722271 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39343 | Film No.: 211399493
SIC: 2834 Pharmaceutical Preparations